Our Vision
AI4Eyes revolutionizes eye care by seamlessly integrating technology (HW & SW) into every aspect of the patient experience.
Our Mission
Our HW & SW platform empowers eye care professionals with AI technology to detect & improve ocular health with speed, consistency, and precision.
Our Values
We make breakthroughs with teamwork
We diagnose with excellence
We drive change through innovation
We center care on patients
We thrive on agility
Global Eye Care Market
$70 billion in 2022
$111.68 billion by 2032
6.72% CAGR
THE EYE CARE REVOLUTION
EYES ARE THE GATEWAY TO OUR HEALTH
The eye serves as a non-invasive gateway to the body's vascular, neural, and connective systems. With advanced imaging, we can revolutionize medical diagnostics.
Eye diagnostics are slow, costly, and often unreliable. Clinics rely on multiple devices, increasing costs and inefficiency. Many diagnoses depend on subjective symptom assessments, leading to delays and misdiagnoses.
The AI Platform That Works for Patients, Eye Care Professionals
& Industry
AI4Eyes is revolutionizing ophthalmic care with a cutting-edge, AI-powered platform that delivers unmatched speed, precision, and efficiency. We offer a compact and modular hardware, paired with end-to-end AI software for fast, accurate, and consistent diagnostics—empowering clinicians and enhancing patient outcomes.
CONSISTENT DIAGNOSIS & REVENUE BOOST
COMPACT & VERSATILE HARDWARE
END-TO-END
SAAS
PLATFORM
MUTIDISCIPLINARY LEADERSHIP
TEAM
AI Empowered Diagnostics
We are transforming the diagnosis and treatment of ocular conditions. Expanding beyond dry eye, our AI-powered platforms will tackle a wide range of eye conditions, driving early detection, precise diagnostics, and improved patient outcomes worldwide.
OSDx Platform
Introducing OSDx, our innovative platform that delivers dry eye assessments in under five minutes, seamlessly integrating hardware and software to optimize patient care and streamline workflows. With real-time clinician feedback, OSDx continuously improves its AI for unmatched diagnostic accuracy.
Global Dry Eye Market
$7.02 billion in 2023
$11.26 billion by 2030
8.1% CAGR
Benefits
> 20%
INCREASED REVENUE
ACCURATE, RELIABLE,
AND FAST DIAGNOSTICS
> 80%
TIME
SAVINGS
SMOOTH & OPTIMIZED
END-TO-END PATIENT EXPERIENCE
65%
INCREASED ENGAGEMENT
PERSONALIZED AND TARGETED INFORMATION
Multidisciplinary Leadership Team
Tara Akhavan, Software PhD
Chief Executive Officer
Tara is a seasoned serial technology entrepreneur with an exit and over 15 years of experience driving growth and innovation in both startups and global corporations. She is a results-oriented leader with a strong track record of scaling revenues, building strategic partnerships, and leading successful M&A processes on both the seller and buyer sides.
With over 10 years of experience managing P&L and driving revenue growth, Tara specializes in B2B SaaS, B2B2C SaaS, and SaaP business models. As the founder of Irystec Software, she pioneered perceptual display technology, leading the company to a successful acquisition by FORVIA in 2020.
A recognized visionary in AI and product strategy, Tara holds a PhD in Image Processing and Computer Vision and has driven groundbreaking advancements in AI across consumer and automotive industries.
Dr. Henry Reis, MD, OD, MBA
Co-founder
Dr. Henry Reis is a physician, author, editor and educator from Rio de Janeiro, Brazil; where he graduated from the University of Brazil (UFRJ), with a summa cum laude Ophthalmology degree. Dr. Reis is the owner of Integra Eyecare, with clinics located in Vancouver and Burnaby, BC.
Dr. Reis has served as the BCDO Vice-President, Chair of the Provincial Telehealth Committee, Editor Emeritus of the CRO Journal, Medical Advisor for I-MED Pharma and professional affairs consultant for multiple industry partners.
Dr. Henry Reis’ recognitions include the 2018 Top 40 under 40 ODs in Canada, the BBOT Top 5 Businessperson of the Year Award in 2019 and 2020 and the 2020 Top 25 Canadian Immigrants Award
Daniel Hofmann, BSc, MBA
Co-founder, Chairman of the Board
Daniel Hofmann is the Chairman and Co-founder of AI4Eyes and the CEO of I-MED Pharma, Canada's leading company specializing in dry eye disease diagnostics and treatment. Under his leadership, I-MED Pharma has consistently achieved over 20% annual growth for the past eight years, establishing its presence in over 20 countries worldwide.
A seasoned entrepreneur with a successful exit, Daniel holds degrees in Biochemistry, Strategic Management, Human Resources, and an MBA from McGill University and HEC Montréal. Passionate about innovation and technology, Daniel is dedicated to advancing ophthalmic solutions, enhancing patient care globally, and maintaining a strong commitment to medical expertise and ethical business practices.
Daniel also serves on several for-profit and non-profit boards in Montreal.
Technical Advisory Board
Medical Advisory Board
Dr. Richard Maharaj
Co-founder of Canadian Dry Eye Summit & Investor
Dr. Pavan Avinashi
CEO of Hollyburn Clinic & Investor
Request the One-Pager & Demo
Want to learn more?
2415 Kingsway, Vancouver, BC V5R 5G8
Montreal, Quebec